Sandra Mangsbo
Legitimerad fysioterapeut, examen i ortopedisk medicin
Utbildning, examen och certifikat
Vetenskapliga publikationer
- Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange. forfattare
- Blood Levels of Dendritic Cell Populations in Patients with Moderate to Severe Traumatic Brain Injury. forfattare
- Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagement. forfattare
- Repeated positron emission tomography tracing neutrophil elastase in a porcine intensive-care sepsis model. forfattare
- A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice. forfattare
- Correction: Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations. forfattare
- MALT1 inhibition suppresses antigen-specific T cell responses. forfattare
- Bridging responses to a human telomerase reverse transcriptase-based peptide cancer vaccine candidate in a mechanism-based model. forfattare
- Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer. forfattare
- Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-lines. forfattare
- Epitopes Displayed in a Cyclic Peptide Scaffold Bind SARS-COV-2 Antibodies. forfattare
- Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers. forfattare
- Whole protein or long peptides in therapeutic vaccination strategies, does it make a difference? forfattare
- Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination. forfattare
- Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection. forfattare
- Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials. forfattare
- Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab. forfattare
- Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time. forfattare
- Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology. forfattare
- Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines. forfattare
- Whole protein or long peptides in therapeutic vaccination strategies, does it make a difference? forfattare
- Abstract A137: The innate/adaptive immune response triggered in response to local immunotherapy of orthotopically growing bladder cancer tumors forfattare
- 842 A novel agonistic anti-CD40 targeting strategy with an affinity peptide binding feature for antigen cargo functionality: improving peptide stability and T cell proliferation forfattare
- Tumor localized agonistic anti-CD40 therapy and beyond forfattare
- Selective FcγR engagement by human agonistic anti-CD40 antibodies forfattare
- Local immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer forfattare
- Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential forfattare
- Blood Levels of Dendritic Cell Populations in Patients with Moderate to Severe Traumatic Brain Injury forfattare
- Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-lines forfattare
- Abstract CT108: Phase I data from TENDU101, a first-in-human trial of a novel synthetic peptide conjugate cancer vaccine platform assessed in recurrent prostate cancer patients before salvage treatment forfattare
- Tim-3 and PD-1: Regulators of adaptive immunity in multiple sclerosis forfattare
- Abstract 1485: Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment forfattare
- A Hexon and Fiber-modified Adenovirus Expressing CD40L Improves the Antigen Presentation Capacity of Dendritic Cells forfattare
- CpG Therapy is Superior to BCG in an Orthotopic Bladder Cancer Model and Generates CD4+ T-cell Immunity forfattare
- Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation forfattare
- Bridging responses to a human telomerase reverse transcriptase-based peptide cancer vaccine candidate in a mechanism-based model forfattare
- Kick-starting the cancer-immunity cycle by targeting CD40 forfattare
- Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients forfattare
- Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment forfattare
- Abstract 501: Early immunological events in the periphery and the TME following a local immunostimulating instillation into the bladder in the MB49 orthotopic model forfattare
Författare och granskare på Skadekompassen
- Ont i höften Författare
- Metatarsalgi Författare
- EPTE - EPI Författare
- Mortons neurom Författare
Tack för att du vill lämna ditt omdöme på Skadekompassen.se. Dina synpunkter hjälper andra att välja och få bra vård.
Tänk på att:
Tips på innehåll:
Så här används informationen du lämnar